Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
11 2020
Historique:
received: 15 03 2019
accepted: 20 08 2019
pubmed: 25 8 2019
medline: 15 12 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

To identify and validate, using computer-driven methods, patterns of arterial disease in Takayasu arteritis (TAK) and giant cell arteritis (GCA). Patients with TAK or GCA were studied from the Diagnostic and Classification Criteria for Vasculitis (DCVAS) cohort and a combined North American cohort. Case inclusion required evidence of large-vessel involvement, defined as stenosis, occlusion, or aneurysm by angiography/ultrasonography, or increased A total of 1,068 patients were included (DCVAS cohort: TAK = 461, GCA = 217; North American cohort: TAK = 225, GCA = 165). Six distinct clusters of patients were identified in DCVAS and validated in the North American cohort. Patients with TAK were more likely to have disease in the abdominal vasculature, bilateral disease of the subclavian and carotid arteries, or focal disease limited to the left subclavian artery than GCA (P < 0.01). Patients with GCA were more likely to have diffuse disease, involvement of bilateral axillary/subclavian arteries, or minimal disease without a definable pattern than TAK (P < 0.01). Patients with TAK were more likely to have damage by angiography, and patients with GCA were more likely to have arterial FDG uptake by PET without associated vascular damage. Arterial patterns of disease highlight both shared and divergent vascular patterns between TAK and GCA and should be incorporated into classification criteria for large-vessel vasculitis.

Identifiants

pubmed: 31444857
doi: 10.1002/acr.24055
pmc: PMC7035996
mid: NIHMS1047598
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1615-1624

Subventions

Organisme : NCATS NIH HHS
ID : U2C TR002818
Pays : United States
Organisme : NIAMS NIH HHS
ID : U54 AR057319
Pays : United States
Organisme : NCRR NIH HHS
ID : U54 RR019497
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 AR999999
Pays : United States

Informations de copyright

Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Références

Am J Hum Genet. 2017 Jan 5;100(1):64-74
pubmed: 28041642
Chest. 1975 Jan;67(1):69-74
pubmed: 14812
Lancet. 2016 May 7;387(10031):1921-7
pubmed: 26952547
Ann Rheum Dis. 2012 Aug;71(8):1329-34
pubmed: 22328740
N Engl J Med. 2017 Jul 27;377(4):317-328
pubmed: 28745999
Arthritis Rheum. 2006 Feb 15;55(1):131-7
pubmed: 16463425
Rheumatology (Oxford). 2015 Mar;54(3):463-70
pubmed: 25193809
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):99-106
pubmed: 29799393
Am Heart J. 1977 Jan;93(1):94-103
pubmed: 12655
Arthritis Rheumatol. 2017 Apr;69(4):837-845
pubmed: 28133925
Arthritis Rheumatol. 2015 May;67(5):1361-8
pubmed: 25604533
Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e205-e213
pubmed: 28774474
Arthritis Rheumatol. 2018 Mar;70(3):439-449
pubmed: 29145713
Medicine (Baltimore). 2009 Jul;88(4):221-6
pubmed: 19593227
Arthritis Rheum. 2011 Apr;63(4):1136-40
pubmed: 21452331
Semin Arthritis Rheum. 2015 Jun;44(6):724-8
pubmed: 25712813
J Rheumatol. 2015 Feb;42(2):300-8
pubmed: 25399386
Clin Exp Nephrol. 2013 Oct;17(5):619-621
pubmed: 23996327
J Rheumatol. 2015 Feb;42(2):149-51
pubmed: 25641963
Int J Cardiol. 1996 Aug;54 Suppl:S155-63
pubmed: 9119518
Ann Rheum Dis. 2018 Aug;77(8):1165-1171
pubmed: 29666047
Ann Rheum Dis. 2018 Mar;77(3):348-354
pubmed: 29191819
Arthritis Rheum. 1990 Aug;33(8):1122-8
pubmed: 2202311
Acta Pathol Microbiol Scand Suppl. 1973;237:Suppl 237:1-59
pubmed: 4151114
J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24
pubmed: 17084256
Arthritis Rheumatol. 2017 Apr;69(4):846-853
pubmed: 28133931
Arthritis Rheum. 1990 Aug;33(8):1129-34
pubmed: 1975175
Ann Rheum Dis. 2012 Jul;71(7):1170-6
pubmed: 22267328
Clin Exp Immunol. 2011 May;164 Suppl 1:11-3
pubmed: 21447123
Acta Med Scand Suppl. 1972;533:135-59
pubmed: 4508179

Auteurs

K Bates Gribbons (KB)

National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland.

Cristina Ponte (C)

Hospital de Santa Maria, Lisbon, Portugal.

Simon Carette (S)

Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Anthea Craven (A)

University of Oxford, Oxford, UK.

David Cuthbertson (D)

University of South Florida, Tampa.

Gary S Hoffman (GS)

Cleveland Clinic Foundation, Cleveland, Ohio.

Nader A Khalidi (NA)

McMaster University, Hamilton, Ontario, Canada.

Curry L Koening (CL)

University of Utah, Salt Lake City.

Carol A Langford (CA)

Cleveland Clinic Foundation, Cleveland, Ohio.

Kathleen Maksimowicz-McKinnon (K)

Henry Ford Health System, Detroit, Michigan.

Carol A McAlear (CA)

University of Pennsylvania, Philadelphia.

Paul A Monach (PA)

Veterans Affairs Boston Healthcare System, Boston, Massachusetts.

Larry W Moreland (LW)

University of Pittsburgh, Pennsylvania.

Christian Pagnoux (C)

Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Kaitlin A Quinn (KA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland, and Georgetown University, Washington, DC.

Joanna C Robson (JC)

University of the West of England, Bristol, UK.

Philip Seo (P)

Johns Hopkins University, Baltimore, Maryland.

Antoine G Sreih (AG)

University of Pennsylvania, Philadelphia.

Ravi Suppiah (R)

Auckland District Health Board, Auckland, New Zealand.

Kenneth J Warrington (KJ)

Mayo Clinic, Rochester, Minnesota.

Steven R Ytterberg (SR)

Mayo Clinic, Rochester, Minnesota.

Raashid Luqmani (R)

University of Oxford, Oxford, UK.

Richard Watts (R)

Norwich Medical School, University of East Anglia, Norwich, and University of Oxford, Oxford, UK.

Peter A Merkel (PA)

University of Pennsylvania, Philadelphia.

Peter C Grayson (PC)

National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH